Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma
Sponsor: Ohio State University Comprehensive Cancer Center
Summary
This trial studies how well nanochip technology (immuno-tethered lipoplex nanoparticle \[ILN\] biochip) works in monitoring treatment response and in detecting relapse in participants with diffuse large B-cell lymphoma. Finding genetic markers for diffuse large B-cell lymphoma may help identify participants with this disease and help predict the outcome of treatment. It is not yet known how well ILN biochip-based testing monitors treatment response or detects relapse in participants with diffuse large B-cell lymphoma.
Official title: A Pilot Study of Nanochip Technology for Monitoring Treatment Response and Detection of Relapse in Patients With Diffuse Large B-Cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
73
Start Date
2018-09-26
Completion Date
2026-07-01
Last Updated
2025-12-18
Healthy Volunteers
No
Conditions
Interventions
Molecular Nanotechnology
Undergo ILN biochip testing
Locations (1)
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States